3/5
08:29 am
tndm
Rating for TNDM
Low
Report
Rating for TNDM
3/5
08:29 am
tndm
Rating for TNDM
Low
Report
Rating for TNDM
3/5
08:08 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $22.00 price target on the stock, down previously from $45.00.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $22.00 price target on the stock, down previously from $45.00.
3/5
08:08 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $22.00 price target on the stock, down previously from $45.00.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $22.00 price target on the stock, down previously from $45.00.
3/5
06:08 am
tndm
Tandem Diabetes downgraded to Equal Weight from Overweight at Morgan Stanley
Low
Report
Tandem Diabetes downgraded to Equal Weight from Overweight at Morgan Stanley
3/5
06:08 am
tndm
Tandem Diabetes downgraded to Equal Weight from Overweight at Morgan Stanley
Low
Report
Tandem Diabetes downgraded to Equal Weight from Overweight at Morgan Stanley
3/4
08:01 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock, down previously from $35.00.
Medium
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock, down previously from $35.00.
3/4
06:18 am
tndm
Rating for TNDM
Medium
Report
Rating for TNDM
3/4
06:18 am
tndm
Rating for TNDM
Medium
Report
Rating for TNDM
3/4
05:19 am
tndm
Tandem Diabetes downgraded to Neutral from Buy at Citi
Medium
Report
Tandem Diabetes downgraded to Neutral from Buy at Citi
3/3
10:23 am
tndm
Rating for TNDM
Low
Report
Rating for TNDM
3/3
10:23 am
tndm
Rating for TNDM
Low
Report
Rating for TNDM
3/3
10:23 am
tndm
Rating for TNDM
Low
Report
Rating for TNDM
3/3
08:10 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $22.00 price target on the stock, down previously from $38.00.
Medium
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $22.00 price target on the stock, down previously from $38.00.
3/3
06:21 am
tndm
Rating for TNDM
Medium
Report
Rating for TNDM
3/3
06:21 am
tndm
Rating for TNDM
Medium
Report
Rating for TNDM
3/3
05:17 am
tndm
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
Medium
Report
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
3/3
05:17 am
tndm
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
Medium
Report
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
2/28
04:49 pm
tndm
Rating for TNDM
Medium
Report
Rating for TNDM
2/28
04:49 pm
tndm
Rating for TNDM
Medium
Report
Rating for TNDM
2/28
09:06 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $25.00 price target on the stock, down previously from $35.00.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $25.00 price target on the stock, down previously from $35.00.
2/28
08:46 am
tndm
Tandem Diabetes downgraded to Market Perform from Outperform at Bernstein
Low
Report
Tandem Diabetes downgraded to Market Perform from Outperform at Bernstein
2/28
08:46 am
tndm
Tandem Diabetes downgraded to Market Perform from Outperform at Bernstein
Low
Report
Tandem Diabetes downgraded to Market Perform from Outperform at Bernstein
2/27
12:17 pm
tndm
Rating for TNDM
Low
Report
Rating for TNDM
2/27
12:17 pm
tndm
Rating for TNDM
Low
Report
Rating for TNDM